Lysteria encephalitis associated to infliximab administration [3];Encefalitis por Listeria asociada a tratamiento con infliximab

Revista Clinica Espanola

Volumn 205, Issue 5, 2005, Pages 250-

  Cabades O'Callaghan F ^a   Vila Fayos, V ^a   Arnal Babiloni, M ^a   Polo Sanchez J A ^a  

^a Hospital Comarcal de Vinaros   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CORTICOSTEROID; GENTAMICIN; INFLIXIMAB; METHOTREXATE;

AGED; CASE REPORT; DRUG EFFICACY; DRUG RESPONSE; ENCEPHALITIS; HUMAN; LETTER; LISTERIA MONOCYTOGENES; LISTERIOSIS; MALE; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS;

EID: 21344486115     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13075582     Document Type: Letter

References (7)

1. Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedreld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Eng J Med. 2000;343:1594.
2. Sanmartí R, Gratacós J. Infliximab: nuevos horizontes en el tratamiento de la artritis. Rev Esp de Reumatología. 2002; 1:1.
3. Slifman NR, Gershon SK, Lee JH, Edwards ET, Braun MM. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum. 2003;48:319-24.
4. Kollias G. Tumor necrosis factor: a specific trigger in arthritis. 51st Forum in Immunology. 1994:342.
5. Schuchat A, Deaver KA, Wenger JD, Plikaytis BD, Mascola L, Pinner RW, et al. Role of foods in sporadic listeriosis. I case-control study of dietary risk factors. The Listeria Study Group. JAMA. 1992;267:2041.
6. Nieman RE, Lorber B. Listeriosis in adults: a changing patern. Report of eight cases and review of the literature, 1968-1978. Rev Infect Dis. 1980; 2:207-27.
7. Chalmeta C, Cortés R, Vela P, de la Torre J, Ruiz JM, Mas P, et al. Tncidencia de reacciones adversas en pacientes tratados con infliximab: experiencia tras dos años de tratamiento. Rev Esp Reumatol. 2002;29: 211-2.